(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 28.19% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.59%.
Clearpoint Neuro's revenue in 2025 is $34,332,000.On average, 4 Wall Street analysts forecast CLPT's revenue for 2025 to be $1,061,098,934, with the lowest CLPT revenue forecast at $1,008,345,275, and the highest CLPT revenue forecast at $1,104,245,516. On average, 4 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,609,043,466, with the lowest CLPT revenue forecast at $1,504,161,459, and the highest CLPT revenue forecast at $1,701,134,984.
In 2027, CLPT is forecast to generate $2,139,592,933 in revenue, with the lowest revenue forecast at $2,055,687,328 and the highest revenue forecast at $2,202,522,137.